Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection
Medical Journal Armed Forces India (2021) - Comments
pubmed: 34334898  doi: 10.1016/j.mjafi.2021.02.007  issn: 0377-1237 

Salil Gupta, Prashant Kumar Dixit, Parthasarathi Ghana, Kumar Abhisheka, Harshit Khurana, Vijoy Kumar Jha, Debasish Mahapatra, Jitesh Goel, Safia Ahmed, G. Varadaraj